OCTIOCOR LTD
Company number 13840221 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£166,572
Balance sheet as at 2025-03-31
What it does
The principal activity of the company during the year under review was the research and experimental development of biotechnology.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2022-01-11
- Employees
- 2 (2025 accounts · was 1 in 2024)
- Registered office
- Allia Future Business Centre The Guildhall, Market Square, Cambridge, England, CB2 3QJ
- Postcode
- CB2 3QJ
- Capital
- 1 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-01-14
- Next due by
- 2027-01-28
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 1 resigned
Nathalie Jayne, Dr HAYES
Director
Hayley Patricia, Dr FRENCH
Director
Michael Thomas ROBERTS
Director
Jason Alexander, Dr MELLAD
Director
Martin Richard, Professor BENNETT
Director
Contact details
- Website
- octiocor.com
Life-saving heart attack prevention. Improve patient outcomes with precision cardiology imaging.
Competitors Cambridge
This company ranks 84 among research and experimental development on biotechnology in Cambridge.